Insider · CIK 0001589991

Cagle Gerald D.

Reports to the SEC for 3 companies · BEDMINSTER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001589991

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-06-17	AERIE PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+7,800 sh	—	—	7,800
2021-06-17	AERIE PHARMACEUTICALS INCA Award	Director	AAward	+1,750 sh	—	—	20,050
2021-06-02	CALCCalciMedica, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2020-09-29	CALCCalciMedica, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−3,322 sh	—	—	0
2020-09-29	CALCCalciMedica, Inc.C Conversion	Director	CConversion	+3,322 sh	—	—	3,322
2020-09-24	CALCCalciMedica, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2020-06-11	AERIE PHARMACEUTICALS INCA Award	Director	AAward	+1,750 sh	—	—	18,300
2020-06-11	AERIE PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+7,800 sh	—	—	7,800
2020-05-08	AERIE PHARMACEUTICALS INCS Sale	Director	SSale	−5,000 sh	$15.27	−$76.4K	16,550
2019-05-23	AERIE PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+7,800 sh	—	—	7,800
2019-05-23	AERIE PHARMACEUTICALS INCA Award	Director	AAward	+1,750 sh	—	—	21,550
2018-11-16	AERIE PHARMACEUTICALS INCP Purchase	Director	PPurchase	+2,000 sh	$41.75	+$83.5K	19,800
2018-06-25	CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,618 sh	—	—	0
2018-06-25	CLSDQClearside Biomedical, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,618 sh	$8.81	+$75.9K	77,513
2018-06-25	CLSDQClearside Biomedical, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,632 sh	$9.11	+$24K	80,145
2018-06-25	CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,632 sh	—	—	0
2018-06-20	CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2018-06-07	AERIE PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+7,800 sh	—	—	7,800
2018-06-07	AERIE PHARMACEUTICALS INCA Award	Director	AAward	+1,750 sh	—	—	17,800
2018-05-25	AERIE PHARMACEUTICALS INCP Purchase	Director	PPurchase	+1,000 sh	$49.45	+$49.5K	16,050
2018-05-21	AERIE PHARMACEUTICALS INCP Purchase	Director	PPurchase	+1,000 sh	$50.24	+$50.2K	15,050
2018-05-11	CLSDQClearside Biomedical, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+45.5K sh	$0.40	+$18.2K	68,895
2018-05-11	CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−45.5K sh	—	—	0
2018-03-22	CLSDQClearside Biomedical, Inc.P Purchase	Director	PPurchase	+7,500 sh	$11.89	+$89.2K	23,441
2017-08-11	CLSDQClearside Biomedical, Inc.P Purchase	Director	PPurchase	+5,000 sh	$7.08	+$35.4K	15,941
2017-06-30	CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,632 sh	—	—	2,632
2017-06-22	CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,618 sh	—	—	8,618
2017-06-08	AERIE PHARMACEUTICALS INCA Award	Director	AAward	+1,150 sh	—	—	14,050
2017-06-08	AERIE PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2017-05-09	AERIE PHARMACEUTICALS INCP Purchase	Director	PPurchase	+1,000 sh	$39.90	+$39.9K	12,900
2017-04-19	AERIE PHARMACEUTICALS INCP Purchase	Director	PPurchase	+1,000 sh	$41.80	+$41.8K	11,900
2017-04-19	AERIE PHARMACEUTICALS INCP Purchase	Director	PPurchase	+1,000 sh	$41.60	+$41.6K	10,900
2017-03-27	CLSDQClearside Biomedical, Inc.P Purchase	Director	PPurchase	+14.1K sh	$7.10	+$99.9K	14,064
2017-03-16	CLSDQClearside Biomedical, Inc.P Purchase	Director	PPurchase	+5,000 sh	$6.84	+$34.2K	10,941
2016-06-08	AERIE PHARMACEUTICALS INCA Award	Director	AAward	+1,700 sh	—	—	9,900
2016-06-08	AERIE PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2016-06-07	CLSDQClearside Biomedical, Inc. · Warrant to Purchase Common Stock (right to buy)X Exercise of In-Money	Director	XExercise of In-Money	−470 sh	—	—	0
2016-06-07	CLSDQClearside Biomedical, Inc.C Conversion	Director	CConversion	+4,261 sh	—	—	5,473
2016-06-07	CLSDQClearside Biomedical, Inc.X Exercise of In-Money	Director	XExercise of In-Money	+470 sh	$0.02	+$10.34	5,943
2016-06-07	CLSDQClearside Biomedical, Inc.S Sale	Director	SSale	−2 sh	$7.00	−$14	5,941
2016-06-07	CLSDQClearside Biomedical, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−9,375 sh	—	—	0
2015-08-28	AERIE PHARMACEUTICALS INCP Purchase	Director	PPurchase	+476 sh	$16.60	+$7,901.552	8,200
2015-08-28	AERIE PHARMACEUTICALS INCP Purchase	Director	PPurchase	+1,524 sh	$16.60	+$25.3K	7,724
2015-08-12	AERIE PHARMACEUTICALS INCP Purchase	Director	PPurchase	+500 sh	$15.46	+$7,729.25	6,200
2015-08-10	AERIE PHARMACEUTICALS INCP Purchase	Director	PPurchase	+100 sh	$16.31	+$1,631	4,654
2015-08-10	AERIE PHARMACEUTICALS INCP Purchase	Director	PPurchase	+100 sh	$16.35	+$1,635	4,854
2015-08-10	AERIE PHARMACEUTICALS INCP Purchase	Director	PPurchase	+846 sh	$16.39	+$13.9K	5,700
2015-08-10	AERIE PHARMACEUTICALS INCP Purchase	Director	PPurchase	+100 sh	$16.34	+$1,634.5	4,754
2015-04-10	AERIE PHARMACEUTICALS INCA Award	Director	AAward	+1,700 sh	—	—	3,554
2015-04-10	AERIE PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Jun 214
Cagle Gerald D.0001209191-21-041979
SEC(opens sec.gov)
Jun 44
Cagle Gerald D.0001209191-21-038392
SEC(opens sec.gov)
Sep 294
Cagle Gerald D.0001209191-20-052338
SEC(opens sec.gov)
Sep 284
Cagle Gerald D.0001209191-20-052241
SEC(opens sec.gov)
Jun 294
Cagle Gerald D.0001209191-20-039265
SEC(opens sec.gov)
May 124
Cagle Gerald D.0001209191-20-028588
SEC(opens sec.gov)
May 234
Cagle Gerald D.0001209191-19-032411
SEC(opens sec.gov)
Nov 194
Cagle Gerald D.0001209191-18-059222
SEC(opens sec.gov)
Jun 264
Cagle Gerald D.0001209191-18-039537
SEC(opens sec.gov)
Jun 214
Cagle Gerald D.0001209191-18-038979
SEC(opens sec.gov)
Jun 84
Cagle Gerald D.0001209191-18-036809
SEC(opens sec.gov)
May 254
Cagle Gerald D.0001209191-18-033483
SEC(opens sec.gov)

Companies

Address

C/O AERIE PHARMACEUTICALS, INC. 135 U.S. HIGHWAY 206, SUITE 15

BEDMINSTER, NJ, 07921